Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Fitness to practise

Pharmacy2U directors face fitness to practise committee over sale of patient data

The pharmacist directors of online pharmacy company Pharmacy2U have been referred to a General Pharmaceutical Council (GPhC) fitness-to-practise hearing over allegations relating to the sale of patient data.

The GPhC’s investigating committee decided to refer commercial director Julian Harrison and managing director Daniel Lee after Pharmacy2U was fined £130,000 by the Information Commissioner’s Office (ICO) for selling patient data to marketing companies.

Harrison is alleged to have authorised the sale of patient data to third parties, while Lee is alleged to have failed to ensure robust procedures were in place on the company’s website that would have allowed patients to provide informed consent to the use of their data.

The ICO  — the independent UK organisation that upholds information rights and promotes data privacy for individuals — imposed its fine in October 2015 following an investigation. More than 100,000 customer details were advertised for sale by Pharmacy2U, at a cost of £130 per 1,000 records. The database was advertised as including people with a range of conditions such as asthma, Parkinson’s disease and erectile dysfunction, and a breakdown of the data was available.

The ICO found that the Leeds-based company had breached the Data Protection Act for failing to inform customers that their personal details were being sold and for failing to seek their consent.

The pharmacists will face the GPhC’s fitness to practise committee on 23–25 May 2016.

  • This article was amended on 7 April 2016 to correct an inaccuracy. The pharmacists will face the GPhC’s fitness to practise committee, not the investigating committee as originally stated.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200973

Readers' comments (2)

  • Good - they should be struck off. We are here to protect patients NOT sell private details to companies who are going to harass patients especially elderly patients in order to make a profit.

    Unsuitable or offensive? Report this comment

  • Get rid of the low volume Pharmacies and keep supporting the big boys Message to all the negotiating bodies and the Government.

    oops Pharmacy to You made £130k
    Small change compared to Wellingtons only £30 million

    Well done Mr Hunt . At least the big boys will contribute by paying taxes .No?? Oh well Panama is your answer.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Pharmacy2U website

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.